Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Disease × Capecitabine × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 16 Breast Neoplasms 16 Rectal Neoplasms 14 Nasopharyngeal Carcinoma 8 Stomach Neoplasms 6 Triple Negative Breast Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Cholangiocarcinoma 3 Carcinoma, Hepatocellular 3 Adenocarcinoma 3 Recurrence 2 Pancreatic Neoplasms 2 HER2-positive Gastric Cancer 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Solid Tumors 1 Resectable Colon Cancer 1 Rectal Neoplasms Malignant 1 Rectal Cancer Patients 1 Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1 Pathologic Complete Response 1 Pancreatic Cancer Resectable 1 Pancreatic Cancer Non-resectable 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Cancinoma (NPC) 1 Mouth Neoplasms 1 Metastatic Breast Cancer in the Brain 1 MSI-H Colorectal Cancer 1 Locally Advanced Rectal Cancer (LARC) 1

Interventions

Tomography, X-Ray Computed 2 Colonoscopy 2 gilteritinib 1 Surveys and Questionnaires 1 Standard of Care 1 Sequence Analysis, RNA 1 Preoperative Exercise 1 Nutritional Status 1 Nutrition Assessment 1 Methods 1 Liquid Biopsy 1 Hysterectomy 1 Exercise 1 Endoscopy 1 Educational Status 1 Drug Therapy 1 Diagnostic Tests, Routine 1 DNA 1 Capecitabine 1 Bupivacaine 1 Bevacizumab 1 Acupressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07134101 2025-08-29

SMARTi-RC01

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting

Gastrointestinal

Disease, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡